MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Aziyo Biologics Operating Expenses 2011-2026 | AZYO
Annual Operating Expenses Aziyo Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.5 M | 37.4 M | 41.6 M | 46.8 M | 42.1 M | 34.2 M | 28.2 M | 24.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.8 M | 24.2 M | 36 M |
Quarterly Operating Expenses Aziyo Biologics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.06 M | 12.9 M | 10.4 M | 11 M | 11.3 M | 11.3 M | 10.2 M | 9.02 M | 11.7 M | - | 11.9 M | 13.1 M | 11.2 M | - | 10.7 M | 10.2 M | 10 M | - | 8.23 M | 7.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.1 M | 7.06 M | 10.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.2 | -0.45 % | $ 3.43 M |  USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 10.54 | 0.86 % | $ 1.42 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 12.8 | -1.92 % | $ 1.92 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.78 | -12.37 % | $ 277 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.37 | 0.12 % | $ 601 M |  Israel |
 |
Butterfly Network
BFLY
|
123 M | $ 4.04 | -5.28 % | $ 855 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.66 | -3.66 % | $ 35.9 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 71.52 | 0.38 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.86 | -4.93 % | $ 144 M |  France |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.87 | -0.83 % | $ 1.14 B | USA |
 |
Establishment Labs Holdings
ESTA
|
185 M | $ 64.93 | -0.12 % | $ 1.92 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 107.89 | -2.58 % | $ 188 B | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.45 | -2.98 % | $ 339 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 270.01 | 0.23 % | $ 7.62 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.7 | -2.96 % | $ 392 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.1 | -3.46 % | $ 1.28 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 31.03 | -5.25 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 173.18 | -1.67 % | $ 13 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 8.9 | -2.25 % | $ 685 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 34.44 | 2.07 % | $ 5.13 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
39.5 M | $ 3.7 | -1.07 % | $ 152 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.42 | 7.69 % | $ 43.2 M | USA |
 |
IRadimed Corporation
IRMD
|
38.2 M | $ 101.65 | -1.12 % | $ 1.29 B | USA |